InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Kelly John Alexander, Chief Financial Officer. Director active across 1 companies, notably Precision Biosciences INC. Aggregated, 6 disclosures have been recorded. Total volume traded: €95k. The latest transaction was disclosed on 22 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
3,888 shares
Common Stock
SEC:0001628280-26-003147·
3,888 shares
Common Stock
SEC:0001628280-26-003147:0·
€47,97033,784 shares@ €1.41990.048% mcap46.3% of flow
Common Stock
SEC:0001209191-22-039100:0·
Ideal exit: 19 Mar 2023 (T+270)
34,090 shares
Common Stock
SEC:0001209191-22-035405:0·
€46,60316,677 shares@ €2.79440.047% mcap45.0% of flow
Common Stock
SEC:0001209191-22-020337:0·
Ideal exit: 12 Dec 2022 (T+270)
€9,025998 shares@ €9.0430.0090% mcap8.7% of flow
Common Stock
SEC:0001209191-22-016614:0·
6 of 6 declarations
About Kelly John Alexander
John Alexander Kelly is the Chief Financial Officer of Precision Biosciences Inc. He oversees the financial management of the company, including budgeting and financial reporting, thereby contributing to the financial health of the company.
